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Abstract



Abstract of the thesis entitled “Chemoenzymatic synthesis of biologically active entities and developement of thiolactomycin based compounds as new antitubercular agents” has been divided into four chapters.

Chapter-1: Biotransformations: Introduction and Background Information
This chapter portrays a concise and general account of enzymes. It also brings about a brief account of importance of chirality, classification of lipases and their applications in organic synthesis for various stereoselective transformations. 

Chapter-2: This chapter describes a facile synthesis of all four enantiomers (3S,4S), (3R,4R), (3S,4R) and (3R,4S) of 3-methoxy-4-methylaminopyrrolidine by lipase-mediated kinetic resolution and is divided into two sections. 

Section-A: Chemoenzymatic Synthesis of (3S,4S) and (3R,4R)-3-Methoxy-4-methylaminopyrrolidine
Section-A deals with the synthesis of optically active (3S,4S) and (3R,4R)-3-methoxy-4-methylaminopyrrolidine by lipase-mediated kinetic resolution for the first time. The (3S,4S)-3-methoxy-4-methylaminopyrrolidine 2a is a key intermediate for a new quinolone antitumor agent AG-7352 1. This compound has been claimed to possess equal or superior antitumour activity to those of cis-platin and etoposide and is presently under clinical development as a drug candidate (Figure-1).

Figure 1

	The commercially available diallyl amine 3 has been employed as the starting material. The synthetic strategy involves Cbz protection of dially amine 3 to give compound 4. The ring-closing metathesis of compound 4 employing Grubbs’ catalyst gives Cbz protected 3-pyrroline 5. The pyrrolidine epoxide 6 has been obtained from compound 5 in a two-step procedure. Thus obtained pyrrolidine epoxide 6, upon treatment with sodium azide affords (±)-trans-3-azido-1-Cbz-4-hydroxypyrrolidine 7, the required intermediate for the lipase-mediated kinetic resolution as shown in Scheme 1.

Scheme 1

Reagents and conditions: i) CbzCl, Et3N, CH2Cl2, rt; ii) Grubbs’ catalyst, CH2Cl2, rt; iii) NBS, DMSO-H2O, rt; iv) 1N NaOH, rt; v) NaN3, 1,4-dioxane-H2O, reflux

	The lipase from Pseudomonas cepacia (immobilized on ceramic particles) PS-C has been utilized for the transesterification of compound (±)-7 to provide azido alcohol (3S,4S)-7 in >99% ee and the corresponding azido acetate (3R,4R)-8 in 81% ee as shown in Scheme 2.

Scheme 2

Reagents and conditions: i) lipase PS-C, vinyl acetate, diisopropyl ether, 40 oC; ii) anhydrous K2CO3, CH3OH, rt
	The enantiomerically enriched (3S,4S)-3-azido-1-Cbz-4-hydroxypyrrolidine 7 has been converted to its methyl ether (3S,4S)-9 using CH3I and NaH. The selective reduction of azide functionality of this compound (3S,4S)-9 followed by Boc protection provides (3S,4S)-10. The Cbz deprotection of compound (3S,4S)-10 and followed by Boc protection affords the desired compound (3S,4S)-2b in >99% ee. The other enantiomer (3R,4R)-7 has been successfully converted to (3R,4R)-2b in 81% ee by employing the above sequential reactions as shown in Scheme 3.

Scheme 3

Reagents and conditions: i) CH3I, NaH, DMF, rt; ii) PPh3, THF-H2O, rt; iii) (Boc)2O, Et3N, rt; iv) PHMS, 10% Pd- C, EtOH; v) (Boc)2O, Et3N, rt


Section-B: Chemoenzymatic Synthesis of (3R,4S) and (3S,4R)-3-Methoxy-4-methylaminopyrrolidine
This Section B describes a chemoenzymatic procedure for the synthesis of optically pure (3S,4R) and (3R,4S)-3-methoxy-4-methylaminopyrrolidine by lipase-mediated resolution. (3R,4S)-3-methoxy-4-methylaminopyrrolidine 2b is a unique scaffold that attachment at C-7 position of quinolone carboxylic acid 1 exhibits superior in vitro antibacterial activity than the corresponding racemate (Figure 1).
Figure 1


	The commercially available diallylamine 3 has been employed as the starting material to obtain the desired final compound 2b. The reaction sequence involves Cbz protection of diallyl amine 3 followed by ring-closing metathesis to give Cbz protected 3-pyrroline 5. The formation of epoxide ring from compound 5 and followed by the ring opening of epoxide 6 with NaN3 affords trans-azido alcohol 7. The desired key intermediate (±)-cis-3-azido-1-Cbz-4-hydroxypyrrolidine 10 has been obtained from trans-azido alcohol 7 in a three step procedure, which involves mesylation of compound 7 followed by SN2 displacement reaction of the mesylated product 8 with potassium acetate and finally deacetylation of compound 9 with anhydrous K2CO3 as shown in Scheme 1.

Scheme 1

Reagents and conditions: i) CbzCl, Et3N, CH2Cl2, rt; ii) Grubbs’catalyst, CH2Cl2, rt; iii) NBS, DMSO-H2O, rt; iv) 1N NaOH, rt; v) NaN3, 1,4-dioxane-H2O, reflux; vi) MsCl, Et3N, CH2Cl2, rt; vii) AcOK, DMF, reflux; viii) anhydrous K2CO3, CH3OH, rt


	The lipase catalyzed transesterification of (±)-cis-3-azido-1-Cbz-4-hydroxypyrrolidine 10 has been successfully carried out by using lipase PS-D (Pseudomonas cepacia lipase immobilized on diatomaceous earth) to provide the azido alcohol (3S,4R)-10 in 92% ee and the corresponding azido acetate (3R,4S)-9 in 97% ee (Scheme 2).

Scheme 2

Reagents and conditions: i) lipase PS-D, isopropenyl acetate, diisopropyl ether, 40 oC; ii) anhydrous K2CO3, CH3OH, rt

	The enantiomerically enriched (3R,4S)-3-azido-1-Cbz-4-hydroxypyrrolidine 10 obtained by the lipase mediated kinetic resolution is converted to its methyl ether 11 using CH3I and NaH. The selective reduction of azide functionality of the compound (3R,4S)-11 has been achieved by TPP followed by Boc protection to afford compound (3R,4S)-12. The N-methylation of compound (3R,4S)-12 has been performed with CH3I and NaH to give (3R,4S)-13. Finally the Cbz deprotection of compound (3R,4S)-13 followed by Boc protection provides the desired (3R,4S)-2b in 97% ee. The other enantiomer (3S,4R)-10 has been successfully converted to (3S,4R)-2b in 92% ee by employing the above sequential reactions as shown in Scheme 3.

Scheme 3

Reagents and conditions: i) NaH, CH3I, dry THF; ii) PPh3, THF:H2O, (Boc)2O, Et3N; iii) NaH, CH3I, DMF; iv) 10% Pd-C, PMHS, (Boc)2O, EtOH


Chapter-3: This chapter illustrates a new one-pot reduction and in situ lipase-mediated resolution method for the synthesis of optically active β-azido alcohols from their corresponding keto azides and the application of this protocol towards the synthesis of biologically active tembamide, aegeline and denopamine. This chapter is further divided into two sections.

Section-A: Chemoenzymatic Synthesis of Enantiopure β-Azido Alcohols by One-pot Method
Section A demonstrates the synthesis of optically active β-azidoalcohols by one-pot reduction of the keto azides and in situ lipase-mediated resolution of the racemic azido alcohols. A series of substituted keto azides 1a-f has been reduced to their corresponding racemic azido alcohols () 2a-f employing sodium borohydride in presence of moist aluminia. The racemic azido alcohol thus obtained has been resolved in situ by lipase PS-C mediated transesterification to give chiral β-azido alcohols (R)-2a-f ranging 75->99% ee and the corresponding azido acetates (S)-3a-f in 94->99% ee (Scheme 1).
Scheme 1

Reagents and conditions: i) NaBH4, moist alumina, diisopropyl ether; ii) PS-C lipase, isopropenyl acetate

Section-B: Chemoenzymatic Synthesis of R and S Enantiomers of Tembamide, Aegeline and Denopamine by One-pot Lipase Resolution Protocol 
The application of this new one-pot reduction and in situ lipase-mediated kinetic resolution method has been successfully employed for the synthesis of both the enantiomers of tembamide 1, aegeline 2 and denopamine 3 (Figure 1).

Figure 1

	The key step in the synthesis is the reduction of azidoketone 4a-b by employing NaBH4 and moist alumina in diisopropyl ether and in situ lipase PS-C mediated resolution to afford (R)-azido alcohols 5a and 5b in 98% and >99% ee respectively and the corresponding (S)-azido acetates 6a and 6b in 96% and 80% ee respectively (Scheme 1).




Scheme 1

Reagents and conditions: i) NaBH4, moist alumina, diisopropyl ether; ii) lipase PS-C, isopropenyl acetate; iii) anhydrous K2CO3, CH3OH, rt

	The azido alcohols (R)-5a and (S)-5a obtained by one-pot reduction and in situ lipase-mediated resolution, converts to their corresponding amino alcohols (R)-7 and (S)-7 using 10% Pd-C under H2 atmosphere. These obtained amino alcohols (R)-7 and (S)-7 upon condensation with benzoyl chloride affords (R) and (S)-tembamide 1 in 98% and 96% ee respectively. Where as the condensation of these amino alcohols with trans-cinnamoyl chloride provides (R) and (S)-aegeline 2 in 98% and 96% ee respectively (Scheme 2).

Scheme 2

Reagents and conditions: i) 10% Pd-C, H2, CH3OH, rt; ii) R1COCl, Et3N, CH2Cl2, 0 oC
 

	The azido alcohols (R)-5b and (S)-5b have been reduced to their amino alcohols by treatment with TPP and followed by coupling with 3,4-dimethoxyphenylacetyl chloride to yield the corresponding hydroxy amide (R)- and (S)-8. The amide functionality of the compounds (R) and (S)-8 have been selectively reduced by treatment with BH3-DMS to afford benzylated denopamine (R) and (S)- 9. Finally, the debenzylation of compounds (R)- and (S)-9 have been carried out using 10% Pd-C under H2 atmosphere to provides the desired denopamine (R) and (S)-3 in >99% and 81% ee respectively (Scheme 3).

Scheme 3

Reagents and conditions: i) PPh3, THF:H2O (1:1), rt; ii) 3,4-dimethoxyphenylacetyl chloride, dry THF; iii) BH3-(CH3)2S, THF, rt; iv) 10% Pd-C, H2, CH3OH, rt

Chapter-4: This chapter describes an efficient chemoenzymatic procedure for synthesis of 3,5-dimethyl-5-(hydroxymethyl)-4-(methoxymethoxy)-2,5-dihydro-2-thiophenone, a key intermediate in the synthesis of thiolactomycin and also synthesis and evaluation of  antitubercular activity of new class of thiolactomycin based compounds at C-4 position of thiolactone ring. This chapter has been further divided into two sections.

Section A: Chemoenzymatic Synthesis of 3,5-Dimethyl-5-(hydroxymethyl)-4-(methoxymethoxy)-2,5-dihydro-2-thiophenone, a Precursor of Thiolactomycin
The section-A describes an efficient chemoenzymatic procedure for the synthesis of 3,5-dimethyl-5-(hydroxymethyl)-4-(methoxymethoxy)-2,5-dihydro-2-thiophenone, a key intermediate of naturally occurring 5(R)-thiolactomycin 1 and its enantiomer 5(S)-thiolactomycin 1. The 5(R)-thiolactomycin (TLM) is a thiolactone antibiotic, which selectively inhibits bacterial and plant type II fatty acid synthase (FAS). Fatty acid synthesis plays a crucial function in living cells. TLM has low toxicity, high water solubility made it an attractive lead molecule for Mycobacterium tuberculosis and related strains (Figure 1)

Figure-1


The required intermediate 3,5-dimethyl-5-methylacetate-4-(methoxymethoxy)-2,5-dihydro-2-thiophenone 8 has been prepared from methyl propionyl acetate 2. The methylation of compound 2 followed by bromination and nucleophlic substitution with thioacetic acid affords compound 4. The cyclization of compound 4 has been carried out by employing aq. KOH in ethanol to afford thiolactone 5. The 4-hydroxyl group of thiolactone 5 has been protected with MOMCl and followed by hydroxymethylation at C-5 position by employing LDA and para formaldehyde yields hydroxymethylated thiolactone 7. The acetylation of primary hydroxyl group of compound 7 provides the required precursor (±)-3,5-dimethyl-5-methylacetate-4-(methoxymethoxy)-2,5-dihydro-2-thiophenone 8 in seven steps as shown in Scheme 1.
Scheme 1

Reagents and conditions: i) anhydrous K2CO3, CH3I, dry THF; ii) Br2, CHCl3; iii) AcSH, Et3N, CH2Cl2; iv) KOH, H2O-EtOH; v) MOMCl, DIPEA, CH2Cl2; vi) (HCHO)n, LDA, dry THF; vii) Ac2O, Et3N, CH2Cl2

The lipase-mediated alcoholysis of (±)-8 has been efficiently carried by Carica papaya lipase in n-butanol to provide 3,5-dimethyl-(5R)-methylacetate-4-(methoxymethoxy)-2,5-dihydro-2-thiophenone 8 in 98% ee and the corresponding 3,5-dimethyl-(5S)-(hydroxymethyl)-4-(methoxymethoxy)-2,5-dihydro-2-thiophenone 7 in 94% ee. The deacetylation of (R)-8 has been successfully carried out by lipase from candida rugosa in n-butanol for 5 days to provide the corresponding 3,5-dimethyl-(5R)-(hydroxymethyl)-4-(methoxymethoxy)-2,5-dihydro-2-thiophenone 7 in 98% ee as shown in Scheme 2.

Scheme 2

Reagents and conditions: i) Carica papaya lipase, n-BuOH, DIPE; ii) Candida rugosa lipase, n-BuOH, DIPE
Section-B: Synthesis of a New Class of Thiolactomycin Based Compounds Active Against Mycobacterium tuberculosis
This section-B deals with the synthesis a new class of thiolactomycin based compounds and evaluation of their activity against Mycobacterium tuberculosis cultures. Thiolactomycin (TLM), a thiolactone antibiotic is a selective and reversible inhibitor of the mycobacterial acyl carrier protein dependent dissociated type II fatty acid synthase (FAS). TLM has shown good activity against several strains of Mycobacterium tuberculosis that are resistant to the other drugs and negligible toxicity in mice, which makes it an attractive lead molecule for tuberculosis and related strains. Recent studies reveal that thiolactomycin and its based analogues exhibit significant activity against Mycobacterium tuberculosis.
The commercially available methyl propionyl acetate 1 has been employed as the starting material. The reaction sequence involves methylation of methyl propionyl acetate 1 to afford methylated β-keto ester 2 and selective bromination of compound 2 followed by nucleophilic substitution with thioacetic acid gives thioester 4. Finally cyclization of thioester 4 has been achieved by employing aq. KOH in ethanol to afford the desired thiolactone ring 5 as shown in Scheme 1.

Scheme 1

Reagents and conditions: i) anhydrous K2CO3, CH3I, dry THF; ii) Br2, CHCl3; iii) AcSH, Et3N, CH2Cl2; iv) KOH, H2O-EtOH

The thiolactomycin based analogues have been prepared by the etherification of 4-hydroxyl group of thiolactone 5 with long chain alkyl dibromides to provide monobromo ether derivatives of thiolactone 6a-f. These monobromo ether derivatives 6a-f have been coupled with methyl thioglycolate, N-methyl piperazine and morpholine leads the formation of corresponding derivatives of thiolactone 7a-f, 8a-f and 9a-f as shown in Scheme 2.

Scheme 2

Reagents and conditions: i) Br(CH2)nBr, anhydrous K2CO3, dry acetone, reflux; ii) methyl thioglycolate, anhydrous K2CO3, dry acetone, reflux; iii) N-methyl piperazine, anhydrous K2CO3, dry acetone, reflux; iv) morpholine, anhydrous K2CO3, dry acetone, reflux

	A series of thiolactomycin based compounds 6a-f, 7a-f, 8a–f and 9a-f have been synthesized and evaluated for their antimycobacterial activity against four different mycobacterium cultures M. tuberculosis ATCC27294, M. avium ATCC 49601, M. tuberculosis clinical isolates and M. intracellulare ATCC 13950. One of the compound 7e possessing eight methylene spacer and methyl thioglycolate as linker of thiolactone ring is the most active compound with an MIC value of 1.0-4.0 μg/mL against drug sensitive and resistant strain of M. tuberculosis. Another compound 6f having ten methylene spacer of bromo derivative have shown moderate activity against M. tuberculosis. N-methyl piperazine derivatives of thiolactone 8a and 8c demonstrated good to mild inhibition against mycobacterium cultures. The remaining compounds have shown lower activity.
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